EMPOWER CLINICS INC - EPWCF STOCK NEWS

Empower Clinics Inc. (OTCQB:EPWCF) has opened its flagship clinic, The Medi-Collective, in Etobicoke, Ontario, marking the 8th clinic under its brand. This 3,500 square foot facility offers family medicine, tele-dermatology, and paramedical services, co-located with an independent pharmacy. Currently staffed by four family physicians, Empower plans to expand its specialist services. The opening follows the launch of another clinic in London, Ontario, earlier this year. Empower is actively developing additional clinics, with four in construction and eight in acquisition stages.

Empower Clinics Inc. (OTCQB:EPWCF) has finalized the 100% sale of Sun Valley Health and its subsidiaries to Andrea and Dustin Klein. The transaction, valued at 1,000,000 common shares based on a 10-day VWAP of $0.24 CAD each, allows Empower to concentrate on its integrated healthcare vision. CEO Steven McAuley noted that this divestiture opens doors for new partnerships and strengthens Empower's focus on expanding its other divisions, including Medi-Collective and Kai Medical Laboratory, enhancing its healthcare service offerings across North America.

Empower Clinics has appointed Anthony Tomasello to its Corporate Board, effective immediately. With over 30 years of experience in healthcare, technology, and public markets, Tomasello previously served as Executive Vice President at Stericycle, driving its growth to approximately $1.5 billion in sales. His addition is expected to bolster Empower's ambitious growth plans through innovative integrations in healthcare delivery. Chairman and CEO Steven McAuley emphasized Tomasello's leadership skills as crucial for moving forward with empowerment's healthcare initiatives in North America.

Empower Clinics Inc. (OTCQB:EPWCF) announced the appointment of Carolyn Shields as Senior Vice President of Operations for The Medi-Collective on February 14, 2022. With over 22 years in professional management, Shields will oversee strategic growth initiatives. Her experience includes recruiting 450+ medical professionals and transitioning practices to electronic medical records. Empower also granted stock options for 700,000 shares priced between $0.270 and $0.275, exercisable for five years. This move aligns with Empower's commitment to integrated healthcare solutions across Canada.

Empower Clinics Inc. has announced the launch of four new testing locations in the Dallas, TX area through its subsidiary, Kai Medical Laboratory. These sites will offer RT-PCR and Rapid Antigen tests starting February 14, 2022, servicing the nearly 8 million residents in the Dallas Metroplex. The locations are open seven days a week and are compliant with medical billing for various insurance programs. This expansion aims to improve access to critical healthcare services amidst ongoing health concerns.

Empower Clinics Inc. (OTCQB: EPWCF) announces the relaunch of its Kai Care At Home COVID-19 Collection Kits in Canada, supported by RapidScreen Services. This partnership enables reliable saliva testing with results in 24-48 hours, catering to travel requirements and enhancing testing accessibility for Canadians. The kits will be sold online and through pharmacies. Empower aims to contribute to the reopening of the Canadian economy and expand its testing solutions across North America.

Empower Clinics has appointed Dr. Tyler Coupal as the new British Columbia Medical Director, effective February 1, 2022. The company aims to pursue COVID-19 testing accreditation under the guidelines of the College of Physicians and Surgeons of British Columbia. Dr. Coupal’s leadership is expected to enhance the company’s capabilities in launching testing services. Empower intends to expand testing services for both PCR and Rapid Antigen tests and seeks to partner with various industries. Additionally, 200,000 stock options have been granted to contractors at a price of $0.295 per share.

Empower Clinics closed a private placement financing, raising C$3,000,000 by selling units at $0.20 per unit and convertible debenture units at $1,000 each. Insider purchases included 1.75 million units by CEO Steven McAuley, who entered a securities lending agreement for 6 million shares. Funds will be used for growth and general expenses. The company paid $328,500 in fees and issued 1.6 million warrants. All securities are under a four-month hold period, and the financing is exempt from certain regulations under MI 61-101.